901 related articles for article (PubMed ID: 15642672)
1. Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases.
Vianelli N; Galli M; de Vivo A; Intermesoli T; Giannini B; Mazzucconi MG; Barbui T; Tura S; Baccaranion M;
Haematologica; 2005 Jan; 90(1):72-7. PubMed ID: 15642672
[TBL] [Abstract][Full Text] [Related]
2. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
[TBL] [Abstract][Full Text] [Related]
3. Long term follow-up after splenectomy performed for immune thrombocytopenic purpura (ITP).
Schwartz J; Leber MD; Gillis S; Giunta A; Eldor A; Bussel JB
Am J Hematol; 2003 Feb; 72(2):94-8. PubMed ID: 12555211
[TBL] [Abstract][Full Text] [Related]
4. Overview of 321 patients with idiopathic thrombocytopenic purpura. Retrospective analysis of the clinical features and response to therapy.
Pamuk GE; Pamuk ON; Başlar Z; Ongören S; Soysal T; Ferhanoğlu B; Aydin Y; Ulkü B; Aktuğlu G; Akman N
Ann Hematol; 2002 Aug; 81(8):436-40. PubMed ID: 12224000
[TBL] [Abstract][Full Text] [Related]
5. Twenty years experience with treatment of idiopathic thrombocytopenic purpura in a single department: results in 490 cases.
Schiavotto C; Rodeghiero F
Haematologica; 1993; 78(6 Suppl 2):22-8. PubMed ID: 8039754
[TBL] [Abstract][Full Text] [Related]
6. Role of splenectomy in chronic idiopathic thrombocytopenic purpura.
Srinivasan S; Sabapathy K; Bharadwaj TP; Sethuraman S
J Assoc Physicians India; 2003 Feb; 51():159-62. PubMed ID: 12725258
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of splenectomy in adult chronic immune thrombocytopenia.
Zoghlami-Rintelen C; Weltermann A; Bittermann C; Kyrle PA; Pabinger I; Lechner K; Wenzl E
Ann Hematol; 2003 May; 82(5):290-4. PubMed ID: 12739064
[TBL] [Abstract][Full Text] [Related]
8. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.
Schweizer C; Reu FJ; Ho AD; Hensel M
Ann Hematol; 2007 Oct; 86(10):711-7. PubMed ID: 17622529
[TBL] [Abstract][Full Text] [Related]
9. Chronic idiopathic thrombocytopenic purpura in adult Chinese patients: a retrospective single-centered analysis of 1791 cases.
Li HQ; Zhang L; Zhao H; Ji LX; Yang RC
Chin Med J (Engl); 2005 Jan; 118(1):34-7. PubMed ID: 15642223
[TBL] [Abstract][Full Text] [Related]
10. Laparoscopic splenectomy for immune thrombocytopenic purpura at a teaching institution.
Zheng CX; Zheng D; Chen LH; Yu JF; Wu ZM
Chin Med J (Engl); 2011 Apr; 124(8):1175-80. PubMed ID: 21542991
[TBL] [Abstract][Full Text] [Related]
11. Current management of adult idiopathic thrombocytopenic purpura in practice: a cohort study of 201 patients from a single center.
Zimmer J; Andrès E; Noel E; Koumarianou A; Blicklé JF; Maloisel F
Clin Lab Haematol; 2004 Apr; 26(2):137-42. PubMed ID: 15053808
[TBL] [Abstract][Full Text] [Related]
12. Splenectomy for idiopathic thrombocytopenic purpura: a five-year retrospective review.
Gibson M; Sehon JK; White S; Zibari GB; Johnson LW
Am Surg; 2000 Oct; 66(10):952-4; discussion 955. PubMed ID: 11261623
[TBL] [Abstract][Full Text] [Related]
13. Durability and factors associated with long term response after splenectomy for primary immune thrombocytopenia (ITP) and outcome of relapsed or refractory patients.
Aleem A
Platelets; 2011; 22(1):1-7. PubMed ID: 20964585
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of dapsone as a second-line treatment in non-splenectomized adults with immune thrombocytopenic purpura.
Vancine-Califani SM; De Paula EV; Ozelo MC; Orsi FL; Fabri DR; Annichino-Bizzacchi JM
Platelets; 2008 Nov; 19(7):489-95. PubMed ID: 18979360
[TBL] [Abstract][Full Text] [Related]
15. A follow-up study of 49 adult patients with idiopathic thrombocytopenic purpura treated with high-dose immunoglobulins and anti-D immunoglobulins.
Rodeghiero F; Schiavotto C; Castaman G; Vespignani M; Ruggeri M; Dini E
Haematologica; 1992; 77(3):248-52. PubMed ID: 1330848
[TBL] [Abstract][Full Text] [Related]
16. Response to splenectomy is durable after a certain point in time in adult patients with chronic immune thrombocytopenic purpura.
Johansson E; Engervall P; Landgren O; Grimfors G; Widell S; Rezai S; Björkholm M
Eur J Haematol; 2006 Jul; 77(1):61-6. PubMed ID: 16573739
[TBL] [Abstract][Full Text] [Related]
17. Predictive factors for successful laparoscopic splenectomy in patients with immune thrombocytopenic purpura.
Duperier T; Brody F; Felsher J; Walsh RM; Rosen M; Ponsky J
Arch Surg; 2004 Jan; 139(1):61-6; discussion 66. PubMed ID: 14718278
[TBL] [Abstract][Full Text] [Related]
18. Splenectomy for adult chronic idiopathic thrombocytopenic purpura: experience from a single center in China.
Wang T; Xu M; Ji L; Han ZC; Yang R
Eur J Haematol; 2005 Nov; 75(5):424-9. PubMed ID: 16191093
[TBL] [Abstract][Full Text] [Related]
19. Are the favorable outcomes of splenectomy predictable inpatients with idiopathic thrombocytopenic purpura (ITP)?
Tsereteli Z; Smith CD; Branum GD; Galloway JR; Amerson RJ; Chakaraborty H; Hunter JG
Surg Endosc; 2001 Dec; 15(12):1386-9. PubMed ID: 11965451
[TBL] [Abstract][Full Text] [Related]
20. Rituximab in the management of chronic immune thrombocytopenic purpura: an effective and safe therapeutic alternative in refractory patients.
Peñalver FJ; Jiménez-Yuste V; Almagro M; Alvarez-Larrán A; Rodríguez L; Casado M; Gallur L; Giraldo P; Hernández R; Menor D; Rodríguez MJ; Caballero D; González R; Mayans J; Millán I; Cabrera JR;
Ann Hematol; 2006 Jun; 85(6):400-6. PubMed ID: 16550390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
